440 related articles for article (PubMed ID: 19642533)
1. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
Herceg D; Vrbanec D
Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
[TBL] [Abstract][Full Text] [Related]
2. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
[TBL] [Abstract][Full Text] [Related]
3. [Current trends in pharmacotherapy of breast cancer].
Boér K
Orv Hetil; 2002 Apr; 143(14):725-30. PubMed ID: 11975393
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials.
Estévez LG; Muñoz M; Alvarez I; Fernández Y; García-Mata J; Ruiz-Borrego M; Tusquets I; Seguí MA; Rodríguez-Lescure A; Adrover E; Lluch A
Cancer Treat Rev; 2007 Aug; 33(5):474-83. PubMed ID: 17561350
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant taxanes: more to the story.
Gajria D; Seidman A; Dang C
Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S41-9. PubMed ID: 20805064
[TBL] [Abstract][Full Text] [Related]
7. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
[TBL] [Abstract][Full Text] [Related]
8. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
Tang SC
Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
[TBL] [Abstract][Full Text] [Related]
9. Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.
Cuppone F; Bria E; Carlini P; Milella M; Felici A; Sperduti I; Nisticò C; Terzoli E; Cognetti F; Giannarelli D
Cancer; 2008 Jul; 113(2):238-46. PubMed ID: 18470908
[TBL] [Abstract][Full Text] [Related]
10. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
Sparano JA
Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
[TBL] [Abstract][Full Text] [Related]
11. Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions.
Dang CT
Expert Rev Anticancer Ther; 2006 Mar; 6(3):427-36. PubMed ID: 16503859
[TBL] [Abstract][Full Text] [Related]
12. Combined anthracycline-taxane regimens in the adjuvant setting.
Mamounas EP; Sledge GW
Semin Oncol; 2001 Aug; 28(4 Suppl 12):24-31. PubMed ID: 11552227
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes.
Davis AL; Klitus M; Mintzer DM
Clin Breast Cancer; 2005 Dec; 6(5):421-4. PubMed ID: 16381625
[TBL] [Abstract][Full Text] [Related]
14. Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes.
Tanabe M; Ito Y; Tokudome N; Sugihara T; Miura H; Takahashi S; Seto Y; Iwase T; Hatake K
Breast Cancer; 2009; 16(4):301-6. PubMed ID: 19205831
[TBL] [Abstract][Full Text] [Related]
15. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
16. [Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer].
Bozhok AA; Semiglazov VF; Kletzel' AE; Arzumanov AS; Mel'nikova OA; Paltuev RM; Ivanova OA; Semiglazov VV
Vopr Onkol; 2006; 52(1):7-14. PubMed ID: 16715697
[No Abstract] [Full Text] [Related]
17. Taxanes in the treatment of early breast cancer.
Ring AE; Ellis PA
Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
[TBL] [Abstract][Full Text] [Related]
18. Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer.
Martin M; Mackey J; Vogel C
Breast; 2007 Dec; 16 Suppl 2():S127-31. PubMed ID: 17923408
[TBL] [Abstract][Full Text] [Related]
19. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.
Bedard PL; Di Leo A; Piccart-Gebhart MJ
Nat Rev Clin Oncol; 2010 Jan; 7(1):22-36. PubMed ID: 19997076
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.
Dang C; Hudis C
Clin Breast Cancer; 2006 Apr; 7(1):51-8. PubMed ID: 16764744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
